Cargando…

Acinetobacter spp. bloodstream infection in hematological patients: a 10-year single-center study

PURPOSE: This study investigated the clinical and antimicrobial characteristics of Acinetobacter spp. bloodstream infection (BSI) in hematological patients. Risk factors for 30-day mortality and carbapenem-resistant Acinetobacter spp. (CRA) BSI acquisition were also identified. METHODS: We reviewed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jia, Feng, Xiaomeng, Wang, Jieru, Lin, Qingsong, Zheng, Yizhou, Zhang, Fengkui, Mi, Yingchang, Zhu, Xiaofan, Jiang, Erlie, Xiao, Zhijian, Wang, Jianxiang, Feng, Sizhou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648370/ https://www.ncbi.nlm.nih.gov/pubmed/37964192 http://dx.doi.org/10.1186/s12879-023-08789-6

Ejemplares similares

Clinical characteristics and risk factors of Aeromonas bloodstream infections in patients with hematological diseases
por: Xu, Chunhui, et al.
Publicado: (2022)

Assessment of mortality-related risk factors and effective antimicrobial regimens for treatment of bloodstream infections caused by carbapenem-resistant Pseudomonas aeruginosa in patients with hematological diseases
por: Zhen, Sisi, et al.
Publicado: (2023)

Bloodstream infections due to Carbapenem-Resistant Enterobacteriaceae in hematological patients: assessment of risk factors for mortality and treatment options
por: Zhang, Lining, et al.
Publicado: (2023)

Development of a Risk Prediction Model of Subsequent Bloodstream Infection After Carbapenem-Resistant Enterobacteriaceae Isolated from Perianal Swabs in Hematological Patients
por: Liu, Jia, et al.
Publicado: (2023)

P1511: MUCORMYCOSIS IN PATIENTS WITH HEMATOLOGIC DISEASES: HOW TO IMPROVE THE PROGNOSIS
por: Wang, Jieru, et al.
Publicado: (2023)

Omicron related COVID-19 prevention and treatment measures for patients with hematological malignancy and strategies for modifying hematologic treatment regimes
por: Guo, Wenjing, et al.
Publicado: (2023)

P1508: GUIDE PERSONALIZED ANTIBIOTIC STEWARDSHIP FOR PSEUDOMONAS AERUGINOSA BLOODSTREAM INFECTIONS IN AML PATIENTS: BASED ON A MACHINE LEARNING MODEL
por: Feng, Xiaomeng, et al.
Publicado: (2023)

P1290: UPFRONT ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION CAN PROVIDE SURVIVAL BENEFIT VERSUS HYPOMETHYLATING AGENT IN MYELODYSPLASTIC SYNDROME WITH INCREASED BLASTS I (MDS-IBI)
por: Runzhi, MA, et al.
Publicado: (2023)

P1527: ASSESSMENT OF RISK FACTORS AND ANTIMICROBIAL THERAPY FOR CARBAPENEM-RESISTANT PSEUDOMONAS AERUGINOSA BLOODSTREAM INFECTIONS IN HEMATOLOGICAL PATIENTS
por: Chen, Zhangjie, et al.
Publicado: (2023)

An analysis of 97 previously diagnosed de novo adult acute erythroid leukemia patients following the 2016 revision to World Health Organization classification
por: Qiu, Shaowei, et al.
Publicado: (2017)

Comparison of hematopoietic stem cell transplantation and immunosuppressive therapy as the first-line treatment option for patients with severe hepatitis−associated aplastic anemia
por: Zhang, Xiaoyu, et al.
Publicado: (2023)

P1512: RESISTANCE DIAGNOSTICS TOOL TO COMBAT ANTIBIOTIC RESISTANCE IN HEMATOLOGY WARDS: A MODEL-BASED EVALUATION FROM A LARGE MULTICENTER CASE–CONTROL AND COHORT STUDY
por: Feng, Xiaomeng, et al.
Publicado: (2023)

Laboratory Surveillance of Acinetobacter spp. Bloodstream Infections in a Tertiary University Hospital during a 9-Year Period
por: Spiliopoulou, Anastasia, et al.
Publicado: (2023)

Levamisole Suppresses CD4(+) T-Cell Proliferation and Antigen-Presenting Cell Activation in Aplastic Anemia by Regulating the JAK/STAT and TLR Signaling Pathways
por: Wang, Jiali, et al.
Publicado: (2022)

Clinical and genomic analysis of virulence-related genes in bloodstream infections caused by Acinetobacter baumannii
por: Bai, Bing, et al.
Publicado: (2022)

Clinical Features and Treatment Progress of Invasive Mucormycosis in Patients with Hematological Malignancies
por: Yang, Nuobing, et al.
Publicado: (2023)

Acinetobacter spp. in Gunshot Injuries
por: Elston, James W.T., et al.
Publicado: (2008)

Venetoclax plus hypomethylating agents versus intensive chemotherapy for hematological relapse of myeloid malignancies after allo-HSCT
por: Chen, Zhangjie, et al.
Publicado: (2023)

PB2411: THE EFFICACY OF MODIFIED MELPHALAN AND BUSULFAN-BASED CONDITIONING REGIMEN FOR AUTOLOGOUS-HSCT IN LOW-RISK AND INTERMEDIATE-RISK AML PATIENTS
por: Zhai, Weihua, et al.
Publicado: (2023)

P1308: RUXOLITINIB AS GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS FOR ALLOGENEIC STEM CELL TRANSPLANTATION IN APLASTIC ANEMIA PATIENTS
por: Zhang, Xiaoyu, et al.
Publicado: (2023)

Shewanella spp. Bloodstream Infections in Queensland, Australia
por: Laupland, Kevin B., et al.
Publicado: (2022)

Risk Factors for and Clinical Outcomes of Polymicrobial Acinetobacter baumannii Bloodstream Infections
por: Qian, Zhenhua, et al.
Publicado: (2022)

Acinetobacter baumannii Bloodstream Infections: A Nationwide Study in Israel
por: Nutman, Amir, et al.
Publicado: (2023)

Comparison of colistin monotherapy and non-colistin combinations in the treatment of multi-drug resistant Acinetobacter spp. bloodstream infections: A Multicenter retrospective analysis
por: Balkan, Ilker Inanc, et al.
Publicado: (2015)

Microbiology and prognostic prediction model of bloodstream infection in patients with hematological malignancies
por: Wang, Jinjin, et al.
Publicado: (2023)

PB2589: EFFICACY AND SAFETY OF ABCD IN THE TREATMENT OF INVASIVE ASPERGILLOSIS IN PATIENTS WITH HEMATOLOGIC DISEASES
por: Pang, Aiming, et al.
Publicado: (2023)

Extensively drug-resistant Gram-negative bacterial bloodstream infection in hematological disease
por: Zhou, Li, et al.
Publicado: (2019)

Comparison of multi-omics results between patients with acute myeloid leukemia with long-term survival and healthy controls
por: Song, Yang, et al.
Publicado: (2022)

Carbapenemase-producing Acinetobacter spp. in Cattle, France
por: Poirel, Laurent, et al.
Publicado: (2012)

Colony-stimulating factor 3 receptor (CSF3R) M696T mutation does not impact on clinical outcomes of a Ph+ acute lymphoblastic leukemia patient
por: Chen, Xin, et al.
Publicado: (2021)

Acinetobacter baumannii Genes Required for Bacterial Survival during Bloodstream Infection
por: Subashchandrabose, Sargurunathan, et al.
Publicado: (2015)

Optimizing autologous hematopoietic stem cell transplantation for acute leukemia
por: Pang, Aiming, et al.
Publicado: (2021)

P570: VENETOCLAX PLUS HYPOMETHYLATING AGENTS VERSUS INTENSIVE CHEMOTHERAPY FOR HEMATOLOGICAL RELAPSE OF MYELOID MALIGNANCIES AFTER ALLO-HSCT
por: Chen, Zhangjie, et al.
Publicado: (2023)

Candida Associated Bloodstream Infections in Pediatric Hematology Patients: A Single Center Experience
por: Gokcebay, Dilek Gurlek, et al.
Publicado: (2016)

Clinical Characteristics and Prognosis Analysis of Acinetobacter baumannii Bloodstream Infection Based on Propensity Matching
por: Wang, Jinghui, et al.
Publicado: (2022)

Molecular epidemiology and antimicrobial susceptibility of Pseudomonas spp. and Acinetobacter spp. from clinical samples at Jimma medical center, Ethiopia
por: Sewunet, Tsegaye, et al.
Publicado: (2022)

Polymyxin-Resistant Acinetobacter spp. Isolates: What is Next?
por: Reis, Adriana O., et al.
Publicado: (2003)

Acinetobacter spp. as nosocomial pathogens: Epidemiology and resistance features
por: Almasaudi, Saad B.
Publicado: (2018)

Accurate identification of clinically important Acinetobacter spp.: an update
por: Vijayakumar, Saranya, et al.
Publicado: (2019)

Rare Shewanella spp. associated with pulmonary and bloodstream infections of cancer patients, China: a case report
por: Zhang, Furong, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_96v031su2ipdn6r5ps3b87497a